Elsevier

Phytomedicine

Volume 96, February 2022, 153897
Phytomedicine

Suppression of colorectal carcinogenesis by naringin

https://doi.org/10.1016/j.phymed.2021.153897Get rights and content

Abstract

Background

Colorectal cancer is the third most malignant cancer worldwide. Despite novel treatment options, the incidence and mortality rates of colon cancer continue to increase in most countries, especially in US, European and Asian countries. Colorectal carcinogenesis is multifactorial, including dietary and genetic factors, as well as lacking physical activity. Vegetables and fruits contain high amounts of secondary metabolites, which might reduce the risk for colorectal carcinogenesis. Flavonoids are important bioactive polyphenolic compounds. There are more than 4,000 different flavonoids, including flavanones, flavonoids, isoflavonoids, flavones, and catechins in a large variety of plant.

Hypothesis

Among various other flavonoids, naringin in Citrus fruits has been a subject of intense scrutiny for its activity against many types of cancer, including colorectal cancer. We hypothesize that naringin is capable to inhibit the growth of transformed colonocytes and to induce programmed cell death in colon cancer cells.

Results

We comprehensively review the inhibitory effects of naringin on colorectal cancers and address the underlying mechanistic pathways such as NF-κB/IL-6/STAT3, PI3K/AKT/mTOR, apoptosis, NF-κB-COX-2-iNOS, and β-catenin pathways.

Conclusion

Naringin suppresses colorectal inflammation and carcinogenesis by various signaling pathways. Randomized clinical trials are needed to determine their effectiveness in combating colorectal cancer.

Introduction

Colorectal cancer appears in the large intestine and mostly affects older adults. It occurs as small, benign clumps of cells (polyps) inside the colon, which subsequently becomes malignant (Memariani et al., 2020). Colorectal cancer is considered as the third most malignant neoplasm in the world (Shike et al., 1990). Despite advancements in therapy, the survival rates of colorectal cancer patients did not significantly improve during the past years (Mbah et al., 2020). The mortality rate and incidence of colon cancer continue to increase in most countries, especially in US, European and Asian countries. Colorectal carcinogenesis is multifactorial, including dietary and genetic factors as well as a lack of physical activity (Center et al., 2009). Preventive measures are the best means for the reduction of mortality rates related to colorectal cancer. Excessive amounts of fat and calories are promoters, while high intake of fibers, calcium and micronutrients are suppressants of colorectal carcinogenesis (West and Cairns 1980; Slattery et al., 1988). Dietary modifications decrease the mortality rates of non-hereditary colorectal cancer (Vargas and Alberts 1992). Natural bioactive substances with diverse chemical structures such as phenolic acid containing flavonoids (Sanatkar et al., 2021), and sesquiterpenes including galbanic acid (Sajjadi et al., 2019) now have fundamental potential to influence various types of cancer. Different phytochemicals such as auraptene (Charmforoshan et al., 2021), apigenin (Madunić et al., 2018), genistein, and ferutinin (Naji Reyhani Garmroudi et al., 2021), showed remarkable activity against cancer cells, lipid peroxidation, and bacterial infections . Vegetables and fruits contain high amounts of fibers and several other compounds, which reduce the risk of colorectal carcinogenesis (Fig. 1). High intake of these foods effectively decreased the development of colonic lesions (Espín et al., 2007). The dietary intake of flavonoids such as for prevention, treatment and control of carcinogenesis remains controversial, because of the complex and not fully understood metabolism of flavonoids in the human body (Spilsbury et al., 2012). Flavonoids are important bioactive polyphenolic compounds (Khan et al., 2012). They consist of a chemical scaffold containing 15 carbons with three rings, two of which are benzene rings connected by a three carbon chain (Croft 1998). There are more than 4000 different flavonoids, including flavanones, flavonoids, isoflavonoids, flavones, and catechins in a large variety of plants (Ueng et al., 1999; Ghasemzadeh and Jaafar 2013). Flavonoids are important constituents of the human diet. Typical dietary sources for flavonoids are coffee, tea, juices, cocoa-derived products, fruits, vegetables, and wine (Kris-Etherton et al., 2002; Macready et al., 2014). The amount of flavonoids present in daily diet is approximately 1 g (Di Carlo et al. 1999). In recent years, the interest in bioactive plant compounds has increased due to reported health benefits, including cardioprotective (Cook and Samman 1996), antioxidant (Asgary et al., 1999), anti-hyperglycemic (Rauter et al., 2010), analgesic (Picq et al., 1991), and other pharmacological effects (Gorinstein et al., 2005). Several biologically active flavonoids such as chrysin in nanoliposomes improved antioxidant mineral deposition in the liver (Beyrami et al., 2020). Apigenin-based silver nanoparticles have been suggested as anticancer agent (Zarei et al., 2021).

Various flavonoids, such as naringin, naringenin, catechins, procyanidines, flavonones, flavones, flavonols, isoflavonones, myricetin revealed cytotoxic activity towards cancer cells (Moon et al., 2006; Theodoratou et al., 2007; Pierini et al., 2008). Flavones effectively inhibited growth of transformed colonocytes and induced programmed cell death and differentiation in HT-29 colon cancer cells (Wenzel et al., 2000). The isoflavone genistein encapsulated in chitosan significantly stopped the growth and proliferation of colorectal cancer cells (Rahmani et al., 2020).

The chemical designation of naringin is 4, 5, 7-trihydroxy flavonone 7-rhamnogluco-side (Viswanatha et al., 2017) (Fig. 2). Its molecular sum formula is C27H32O14 and has a molecular weight of 580.4 g/mol. Naringin is a biflavone glycoside discovered in 1857 by De Vry in grape fruit flowers from Java, although De Vry did not published his research work at that time (Rangaswami et al., 1939). The word naringin is likely derived from the Sanskrit language, where narangi means “orange” (Sinclair 1972). The compound is extremely bitter (Braverman 1949) unless converted to 1,3-diphenylpropan-1-one by treatment with a strong base, such as potassium hydroxide, which is approximately 300–1800 times sweeter than sugar with a refreshing taste of menthol (Tomasik 2003). The antioxidant potential of Orange juices appears to be mostly determined by the concentration of anthocyanin in orange juices, because of their overall phenol levels and ability to interact with the biomembrane (Karimi et al., 2012). Naringin is the major component responsible for the bitter taste of grapefruit. Naringin and hesperidin are both flavanone rhamnosyl glucosides with several common features in their structures (Horowitz and Gentili 1969). Naringin is moderately soluble in water and present in the form of chiral isomers, which vary in their amount dependent on the fruit maturity and purification methods (Wilcox et al., 1999).

Section snippets

Botanical sources of naringin

Naringin has been isolated from different plant families and genera (Table 1). Naringin was detected by UPLC-MS/MS in high amount in branches and leaves of Carissa carandas (El-Desoky et al., 2018). Naringin is predominantly found in the juice of grapefruit (Citrus paradisi) (Jourdan et al., 1985) and orange (Citrus sinensis) (Kuhnau 1976). Naringin is also present in other Citrus plants such as C. nobilis, C. junos, C. unshiu, C. tachibana (Guadagni et al., 1973), Artemisia stolonifera,

Therapeutic potential of naringin

Naringin reduced inflammation (Manthey et al., 2001; Chen et al., 2011) as determined by the expression of inflammatory signaling factors such as inducible nitric oxide synthase (iNOS), interleukin-6 (IL-6), interleukin-8 (IL-8), TNF-α, nuclear factor erythroid 2-related factor 2 (NRF2) (Habauzit et al., 2011). In chronic bronchitis induced in guinea pigs, naringin decreased the concentrations of leukotriene B4 and IL-8, myeloperoxidase activity in BALF (bronchoalveolar lavage fluid) and lung

Metabolism and absorption of naringin

Naringin is hydrolyzed in the large intestine into six glycosides, and small amounts of naringenin are metabolized by bacterial enzymes (Kuntz et al., 1999; Shimoda et al., 2010). Upon oral administration, naringin is rapidly absorbed into the blood with two peak concentrations at 15 min and 3 h. Naringin could not be detected 480 min after dosing (Li et al., 2013). After administration of naringin (600 and 1000 mg/kg) through a duodenal cannula, its average Cmax in portal plasma was reached

Acute toxicity studies of naringin

Several toxicity studies showed that naringin is relatively nontoxic and safe (Additives and Feed 2011). Various marketed dietary products recommended a daily intake of 200–1000 mg naringin (Jung et al., 2003). The maximum orally tolerated dose in rats was 16 mg/kg naringin without any harmful effects (Li et al., 2013). Chronic and sub-chronic toxicity studies for 24 and 13 weeks, respectively, demonstrated that doses up to 1250 mg/kg did not cause organ toxicity, but decreased body weight and

Anticancer activity of naringin

Several biologically active polyphenols including flavonoids have proven anticarcinogenic activity (Moon et al., 2006). Naringin has been studied in various types of cancer cells. So and colleaguesstudied naringin along with other flavonoids in human MDA-MB-435 breast carcinoma cells and rodent DMBA-induced mammary tumors. Naringin inhibited the proliferation of both these cells types (So et al., 1996). Froufe and coworkers reported the inhibition of estrone sulfatase by naringin in silico and

Naringin in colorectal cancer

Recent publications with well-designed experimental in vivo protocols demonstrated the protective effect of vegetables and fruits against colorectal carcinogenesis (Vanamala et al., 2006). Scalbert and Williamson calculated that 1250 ml grapefruit and orange juices contain 690 mg Naringin (Scalbert and Williamson 2000). Naringin and its secondary metabolite naringenin (a glucuronide and sulfated form of Naringin) were found in blood and urine of rats upon oral application. Furthermore,

Mechanisms of chemoprevention in colorectal cancer

Polyphenols emerged as promising chemopreventive agents for colorectal cancer because of their ability to target various molecular pathways such as metastasis, angiogenesis, apoptosis, proliferation and inflammatory cytokines (Ramos 2008).

Conclusion

Naringin is one of the most prevalent flavonoids in Citrus species. Naringin has shown profound efficacy against several cancers and including colorectal cancer. Naringin suppressed several cellular pathways involved in colorectal carcinogenesis. Furthermore, Naringin reduced the toxicity if combined along with other therapeutic agents. Hence, it may be considered as a safe agent against colorectal cancer. On the basis of the current data available for Naringin, it is worthwhile to conduct both

CRediT author statement

Bushra Ansari and Yaseen Hussain collected the literature, wrote the paper draft and drew the figures.

Haroon Khan supervised the project and designed the concept of this paper.

Thomas Efferth and Michael Aschner corrected and finalized the writing of the paper.

All data were generated in-house, and no paper mill was used. All authors agree to be accountable for all aspects of work ensuring integrity and accuracy.

Declaration of Competing Interest

The authors declare that there is no conflict of interest.

References (179)

  • E.R. Greene et al.

    Regulation of inflammation in cancer by eicosanoids

    Prostaglandins Other Lipid Mediat.

    (2011)
  • V. Habauzit et al.

    Differential effects of two citrus flavanones on bone quality in senescent male rats in relation to their bioavailability and metabolism

    Bone

    (2011)
  • J.A. Heddle et al.

    The induction of micronuclei as a measure of genotoxicity: a report of the US Environmental Protection Agency Gene-Tox Program

    Mutation Research/Reviews in Genetic Toxicology

    (1983)
  • D.R. Hewish et al.

    Chromatin sub-structure. The digestion of chromatin DNA at regularly spaced sites by a nuclear deoxyribonuclease

    Biochem. Biophys. Res. Commun.

    (1973)
  • L.J. Hofseth et al.

    Nitric oxide in cancer and chemoprevention

    Free Radic. Biol. Med.

    (2003)
  • G.C. Jagetia et al.

    The grapefruit flavanone Naringin protects against the radiation-induced genomic instability in the mice bone marrow: a micronucleus study

    Mutation Research/Genetic Toxicology and Environmental Mutagenesis

    (2002)
  • U. Jung et al.

    Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects

    Clin. Nutr.

    (2003)
  • U.J. Jung et al.

    The hypoglycemic effects of hesperidin and Naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice

    J. Nutr.

    (2004)
  • H. Katoh et al.

    CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis

    Cancer Cell

    (2013)
  • R. Khan et al.

    Chrysin protects against cisplatin-induced colon. toxicity via amelioration of oxidative stress and apoptosis: probable role of p38MAPK and p53

    Toxicol. Appl. Pharmacol.

    (2012)
  • H.-.J. Kim et al.

    Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol fed condition

    Life Sci.

    (2004)
  • S.J. Korsmeyer

    Regulators of cell death

    Trends Genet.

    (1995)
  • P.M. Kris-Etherton et al.

    Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer

    Am. J. Med.

    (2002)
  • S.-.M. Kuo

    Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells

    Cancer Lett.

    (1996)
  • B.G. Lake et al.

    Inhibition of xenobiotic-induced genotoxicity in cultured precision-cut human and rat liver slices

    Mutation Research/Genetic Toxicology and Environmental Mutagenesis

    (1999)
  • V. Lakshmi et al.

    Antifilarial activity in vitro and in vivo of some flavonoids tested against Brugia malayi

    Acta Trop.

    (2010)
  • L. Li et al.

    Comparison of neoeriocitrin and Naringin on proliferation and osteogenic differentiation in MC3T3-E1

    Phytomedicine

    (2011)
  • P. Li et al.

    Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

    Cell

    (1997)
  • P. Li et al.

    Acute and 13 weeks subchronic toxicological evaluation of Naringin in Sprague-Dawley rats

    Food Chem. Toxicol.

    (2013)
  • Y.-.L. Luo et al.

    Naringin attenuates enhanced cough, airway hyperresponsiveness and airway inflammation in a guinea pig model of chronic bronchitis induced by cigarette smoke

    Int. Immunopharmacol.

    (2012)
  • B.T. MacDonald et al.

    Wnt/β-catenin signaling: components, mechanisms, and diseases

    Dev. Cell

    (2009)
  • A.L. Macready et al.

    Flavonoid-rich fruit and vegetables improve microvascular reactivity and inflammatory status in men at risk of cardiovascular disease—FLAVURS: a randomized controlled trial

    Am. J. Clin. Nutr.

    (2014)
  • J. Madunić et al.

    Apigenin: a dietary flavonoid with diverse anticancer properties

    Cancer Lett.

    (2018)
  • O.M. Mbah et al.

    The affordable care act and ethnic disparities in colorectal cancer screening

    Am. J. Prev. Med.

    (2020)
  • B.M. McCartney et al.

    Cell regulation by the Apc protein: apc as master regulator of epithelia

    Curr. Opin. Cell Biol.

    (2008)
  • J.P. Meijerink et al.

    Hematopoietic malignancies demonstrate loss-of-function mutations of BAX

    Blood

    (1998)
  • Scientific Opinion on the safety and efficacy of Naringin when used as a sensory additive for all animal species

    EFSA Journal

    (2011)
  • J.D. Amaral et al.

    The role of p53 in apoptosis

    Discovery medicine

    (2010)
  • D. Anton et al.

    Changes in polyphenols contents and antioxidant capacities of organically and conventionally cultivated tomato (Solanum lycopersicum L.) fruits during ripening

    International Journal of Analytical Chemistry 2017

    (2017)
  • R. Banjerdpongchai et al.

    Induction of human hepatocellular carcinoma HepG2 cell apoptosis by Naringin

    Asian Pac. J. Cancer Prev.

    (2016)
  • J. Behrens et al.

    Functional interaction of β-catenin with the transcription factor LEF-1

    Nature

    (1996)
  • M. Beyrami et al.

    Synthesized chrysin-loaded nanoliposomes improves cadmium-induced toxicity in mice

    Environmental Science and Pollution Research

    (2020)
  • H. Blankson et al.

    Prevention of toxin-induced cytoskeletal disruption and apoptotic liver cell death by the grapefruit flavonoid, Naringin

    Cell Death Differ.

    (2000)
  • K. Boller et al.

    Chemische Mutagenese beim Säuger. Das Knochenmark des Chinesischen Hamsters als in vivo-Testsystem. Hämatologische Befunde nach Behandlung mit Trenimon

    Humangenetik

    (1970)
  • J.B. Braverman

    Citrus products: Chemical composition and Chemical Technology

    (1949)
  • C.A. Camargo et al.

    Naringin inhibits tumor growth and reduces interleukin-6 and tumor necrosis factor α levels in rats with Walker 256 carcinosarcoma

    Anticancer Res.

    (2012)
  • H. Cao et al.

    Protective effect of Naringin on DSS-induced ulcerative colitis in mice

    J. Agric. Food Chem.

    (2018)
  • J. Castillo et al.

    Naringin and neohesperidin levels during development of leaves, flower buds, and fruits of Citrus aurantium

    Plant Physiol.

    (1992)
  • M.M. Center et al.

    International trends in colorectal cancer incidence rates

    Cancer Epidemiol. Biomarkers Prev.

    (2009)
  • E. Charmforoshan et al.

    Antibacterial, antioxidant and melanogenesis inhibitory activity of auraptene, a coumarin from Ferula szowitsiana root

    Nutr. Cancer

    (2021)
  • Cited by (14)

    • Small-molecule drugs of colorectal cancer: Current status and future directions

      2024, Biochimica et Biophysica Acta - Molecular Basis of Disease
    View all citing articles on Scopus
    View full text